338.7 Organ-on-chip platform to model metabolic crosstalk between islets and liver
Shadab Abadpour, Norway
338.1 Islet Isolation after Normothermic Ex Vivo Machine Perfusion of 2 Discarded Human Pancreas Allografts: A Proof of Concept Study
Dr. Catherine Parmentier, Canada
338.2 Oxygenated hypothermic machine perfusion of the pancreas; a porcine circulatory death model to compare a ‘continuous’ and an ‘end-ischaemic’ approach
Mr. Mohamed A Elzawahry, United Kingdom
338.3 Utilization of oxygenated Hemopure based University of Wisconsin solution during simulated procurement, back-benching, and graft implantation to minimize ischemic reperfusion injury in a rat liver transplantation simulated on pump
Dr. Anil Kharga, United States
338.4 Exploring preservation modalities in a split human pancreas model to investigate the effect on the islet isolation outcomes.
Dr. Antoine Buemi MD, Belgium
338.5 Generation of optimally-sized primary human pancreatic microtissues through single cell dissociation and a novel suspension microcavity system is associated with resolution of disrupted organelle ultrastructure and reestablishment of cell-cell interactions
Dr. William E Scott III, United Kingdom
338.6 A conceptual supportive cell based implant for beta cell replacement therapy
Miss Carolin Hermanns, Netherlands
338.8 Cryogenic preservation of perinatal stem cells in DMSO-supplemented or DMSO-free GMP-grade conditions
Dr. Stefan Bencina, Sweden
338.9 Human organotypic co-culture model of pleura